Results 81 to 90 of about 2,084 (194)

Comments on the Article by Arnljots and Economou [Letter]

open access: yesClinical Ophthalmology, 2021
Ricardo Augusto Paletta Guedes Glaucoma Department, Paletta Guedes Eye Institute, Juiz de Fora, MG, BrazilCorrespondence: Ricardo Augusto Paletta GuedesGlaucoma Department, Paletta Guedes Eye Institute, 79 Oscar Vidal Street, Juiz de Fora, MG, BrazilTel ...
Paletta Guedes RA
doaj  

Spotlight on Schlemm’s Canal MicroStent Injection in Patients with Glaucoma

open access: yesClinical Ophthalmology, 2023
Isabella V Wagner,1 Bryan Ang,2 Leticia Checo,1 Derya Simsek,3 Christian Draper,1 Syril Dorairaj1 1Department of Ophthalmology, Mayo Clinic, Jacksonville, FL, USA; 2Department of Ophthalmology, Tan Tock Seng Hospital, Singapore; 3Department of ...
Wagner IV   +5 more
doaj  

The transition of BCVA: iStent eyes and inject W eyes.

open access: yes
The transition of BCVA: iStent eyes and inject W eyes.
Yoshihito Sakanishi (17904254)   +4 more
core   +1 more source

Estudio coste-utilidad de la innovación quirúrgica iStent versus la práctica clínica habitual para el manejo del glaucoma: evitar la ceguera reduciendo la presión intraocular (PIO)

open access: yes, 2020
Màster Universitari en Economia de la Salud i del Medicament. (UPF Barcelona School of Management). Curs 2018-2020Mentor: Juan CabasésPresentamos una evaluación económica partiendo de la modelización del glaucoma primario de ángulo abierto (POAG) a largo
de Unamuno Vera, Pablo
core   +1 more source

Factors affecting cumulative survival: iStent eyes and inject W eyes.

open access: yes
Factors affecting cumulative survival: iStent eyes and inject W eyes.
Yoshihito Sakanishi (17904254)   +4 more
core   +1 more source

Comparison of the Intraocular Pressure-Lowering Effect of Minimally Invasive Glaucoma Surgery (MIGS) iStent Inject W and Hydrus—The 12-Month Real-Life Data

open access: yesDiagnostics
Background/Objectives: To compare the efficacy and safety of Hydrus® Microstent and iStent inject® W implants, in combination with phacoemulsification, for lowering intraocular pressure (IOP) in patients with glaucoma in a real-world clinical setting ...
Cedric Weich   +5 more
doaj   +1 more source

Comparing iStent versus CyPass with or without phacoemulsification in patients with glaucoma: a meta-analysis

open access: yesTherapeutic Advances in Chronic Disease, 2019
Bacground: The aim of this study was to conduct a meta-analysis to compare the overall intraocular pressure (IOP)-lowering effect of iStent or CyPass as isolated procedures or in combination with cataract extraction.
Ali Mahdavi Fard   +3 more
doaj   +1 more source

Tips and technique for stenting the angle with iStent inject W

open access: yesIndian Journal of Ophthalmology. Case Reports
Background: Minimally invasive glaucoma surgeries are a breakthrough and have added significantly to the glaucoma surgical armamentarium in the recent past.
Sushma Tejwani, Ankit A Shah
doaj   +1 more source

Efficacy and safety of ELIOS excimer laser trabeculostomy versus iStent inject as an adjunct to phacoemulsification: a retrospective comparative study

open access: yes
Background/aims Minimally invasive glaucoma surgery (MIGS) procedures are commonly combined with phacoemulsification to provide additional intraocular pressure (IOP) and/or topical medication reduction in patients
Keith R Martin   +13 more
core   +1 more source

Forest plot for pre- and post-operative number of topical glaucoma medications for studies examining iStent insertion with simultaneous phacoemulsification.

open access: yes, 2015
Forest plot for pre- and post-operative number of topical glaucoma medications for studies examining iStent insertion with simultaneous phacoemulsification.
Monali S. Malvankar-Mehta (670496)   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy